openPR Logo
Press release

Breast Cancer Screening Tests Market 2017-2025 Shares, Trend and Growth Report

01-05-2018 01:39 PM CET | Health & Medicine

Press release from: Transparency Market Research

Breast Cancer Screening Tests Market 2017-2025 Shares, Trend

Breast cancer is defined as out of control growth of cells in the breast which have the ability to form a tumor or lump. These lumps or tumors in the breast are easily detectable through an X-ray. Breast cancer can form in the duct, nipple, glands, or other tissues. The most common types of breast cancer are invasive lobular carcinoma, invasive ductal carcinoma, ductal carcinoma in situ, triple negative breast cancer, metastatic breast cancer, and less common being lymphomas or sarcomas and inflammatory breast cancer.

Breast cancer is one of the most common cancers among woman globally and a major cause of mortality. Therefore, early detection is needed for these diseases. Breast cancer is more prevalent in the industrialized countries due to modernized lifestyle; however, the rate of incidence is expected to rise in developing countries.

According to the WHO, in 2012, round 1.7 million new cases of breast cancer were diagnosed globally. According to the American Cancer Society, breast cancer accounts for 1 in 8 cancers diagnosed in women in the U.S. Symptoms of breast cancer may or may not appear in women. Hence, regular screening is necessary to prevent the malignancy. Breast cancer screening is a regular examination to detect breast cancer. Early detection could ensure timely treatment of patients, thereby reducing the mortality rate. Breast cancer screening generally involves mammography, MRI scan, or ultrasound. Mammography is considered to be the best screening test for the detection of breast cancer.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36128

A rise in the standard of living and educational opportunities for women had resulted in late first pregnancy with limited lactation period indirectly leading to fluctuating hormone levels and high risk of breast cancer. Probability of breast cancer increases with age. Hence, rise in geriatric population is a major factor for increase in incidence of breast cancer.

Rise in incidence of breast cancer, growing awareness about breast cancer screening tests, government initiatives for breast cancer screening programs, technical advancements in breast imaging technologies, implementation of national level programs by the government for early diagnosis are the major factors driving the market.

Based on diagnostic test type, the global breast cancer screening tests market can be segmented into blood marker tests, imaging test, genetic test, and immunohistochemistry test. Imaging test is the most commonly used test for the screening of breast cancer. The segment can be further divided into mammography, MRI screening test, molecular breast imaging test, PET scan, and ultrasound. Mammography is the most common test used for the detection of breast cancer. Genetic test can be sub-segmented into fluorescence in situ hybridization and HER gene test. In most developed countries, mammography is included in the breast screening program making it the most popular breast cancer screening test.

In terms of end-user, the global breast screening tests market can be segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. National breast cancer screening awareness programs and awareness about genetic transfer of breast cancer boost the growth of the diagnostic centers segment.

In terms of region, the global breast cancer screening market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Countries such as United States, Germany, United Kingdom, Japan and China capture the maximum share for the population with higher probability of breast cancer. In 2016, these countries accounted for over 60% share of the global North America is anticipated to hold major market share, as 70% of women in the U.S. undergo mammography. Germany is likely to dominate the market in Europe, due to advanced health care infrastructure and government supported screening programs. Availability of screening services in private health care and diagnostic centers is expected to drive the market in developing countries such as India.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=36128<ype=S

Key players in the global breast cancer screening tests market are A&G Pharmaceutical, Inc., Biocrates Life Sciences AG, Metabolomic Technologies, Inc., Myriad Genetics, Siemens Healthcare Diagnostics, Inc., OncoCyte Corporation, POC Medical Systems, Inc., Hologic, Inc., Provista Diagnostics, Inc., and BioTime, Inc.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Breast Cancer Screening Tests Market 2017-2025 Shares, Trend and Growth Report here

News-ID: 887321 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for Breast

Breast Ultrasound Market Research Report and Forecast to 2028 - Conventional Bre …
A breast ultrasound is an imaging method chiefly utilized to screen for tumours and other breast abnormalities. The ultrasound use high-frequency sound waves for the production of detailed images of the inside of the breasts. The global Breast Ultrasound Market is expected to grow at a significant CAGR of 14.6% by 2028. The updated report on the Breast Ultrasound market gives a precise analysis of the value chain assessment for the review
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues. Download Free PDF Brochure on Brest Imaging Market Report Now
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to
Automated Breast Ultrasound Systems – The Future of Breast Screening
Breast cancer is the most commonly diagnosed type of cancer and the second leading cause of death among women, as evident from stats revealed by the National Breast Cancer Foundation. Growing awareness of breast cancer has increased number of women undergoing breast screening and in turn would propel demand for automated breast ultrasound systems (ABUS) in hospitals and diagnostic centers. ABUS enables physicians to screen women, especially with denser breasts
Soaring Instances of Breast Cancer to Propel Breast Imaging Market
"The Report Breast Imaging Market (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging and Others [Breast Thermography & Bioelectric Imaging]) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" An intelligence report on the global breast imaging market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Breast Imaging
What Is A Combined Breast Augmentation With Breast Lift?
Combined Breast Augmentation And Lift: How Is It Performed? Surrounding the areola one incisions is made to remove the excess skin and another vertically incisions is made to the base of breasts starting from low part of the areola. Sometimes the scar is referred to as the “Lollipop scar”. Implants are placed through the incisions made and positioned carefully by the surgeon under the pectoral chest muscle, where the implants can